Last year’s landmark Inflation Reduction Act at long last requires Big Pharma to negotiate with Medicare — its single biggest customer — over the price of some prescription drugs.

Public Citizen spent years working to secure this hard-fought victory over Big Pharma’s greed.

Now companies like Merck, Johnson & Johnson, Bristol Myers Squibb, and Astellas Pharma are suing to block this commonsense reform, which is expected to save taxpayers almost $100 billion in its first decade.

Pharma giant Merck even had the nerve to call the requirement to negotiate directly with Medicare — over the price of just a handful of drugs — “extortion.”

Um ... no.
Big Pharma’s price gouging of the American people is economically destructive and just plain immoral.

We can’t let Big Pharma get away with courtroom maneuvers that would overturn even modest efforts to rein in its seemingly boundless greed.

Join Public Citizen in a message for the CEOs of Merck, Johnson & Johnson, Bristol Myers Squibb, and Astellas Pharma:

Even after you negotiate with Medicare over the price of some drugs, your profits will still be astronomical. Does your greed know no bounds? Stop price gouging the American people. Stop putting unlimited profits before the health and lives of actual human beings. Drop your lawsuits against the provisions in the Inflation Reduction Act that require you to negotiate directly with Medicare, your largest single customer.

Click now to add your name.

Thanks for taking action.

For progress,

- Robert Weissman, President of Public Citizen
 
 
Public Citizen | 1600 20th Street NW | Washington DC 20009 | Unsubscribe